We would love to hear your thoughts about our site and services, please take our survey here.
Getting a tad despondent now....what happened with being at a cliffs edge!!!??
Being resolute here, and hoping that they will pull a rabbit out of the hat!
Looks like a quick pump to me......hope it can be sustained!
As Catchingpigeon has highlighted, the news about their budget appears to be transparent and very informative.
My only reservation, if you can call it this, why not wait for the topline data and if that good, include it within this corporate presentation. Can it not wait for a week or so, to really push home the data!
And your point is?
Like a diagnostic test, regeneron will not be the only drug used. It's an intravenous delivery unlike Foralumab which can be administered as oral or inhaler....much cheaper and probably more effective. Space for many suppliers including TILS!
This will bounce back as there were a few predictions that it would crash about 30% before the next leg up.
There are rumours that some big whales are adjusting their positions by investing more, so it wouldn't surprise me that the price has been kind by the powers to be and allowed them a much cheaper entry price.
Personallly, I think by mid Feb, BTC will be nearing $50k.
0161....just throw him into the green bin, it can bring so much pleasure.
Beware, shorters are bored on a Sunday ...eh Jack and Axe!
I revise my forecasts.....it will be a $2B company by year end.
I think that £5 maybe reached quicker than we all anticipated. It might not be an offer for the company however it could be a deal similar what Merck did with 4D. Now that will certainly add some rocket fuel to £5 and more!
Then buy elsewhere but if you do some research on TILS then you will know the opportunities that can make you some serious money. This isn't necessary a fast burner but as with any biotech companies, the wait may well be worth waiting.
Old news......this was dealt with last year so nice try if looking for a cheaper price!
Apart from Covid19, Tils nasal spra....neurodegenerative diseases such as progressive MS (pro-MS) by delivering Foralumab via nasal administration as well as Chrohns.
Sanotize only competing on Covid , and I believe we're ahead on the trials!
Apologies if this has already been posted:
https://www.sharesmagazine.co.uk/news/shares/omega-diagnostics-advances-on-virus-antibody-home-test-kit-hopes
So if we had rocketed today then how many shorters would be out on the town today!!!!
Boot et al, and the same will apply to some of the blatant rampers..... We shall see in a couple of months where we are!
As Candid has quite rightly pointed out, the true valuation of this share will be realised with the cross trading on the US venture market.
There are also many pie in the sky valuations for Bitcoin so if any come to fruition over the next 2-3 yes then this will release accordingly. Wouldn't be surprised to see £2 plus but I'm being conservative!